Increase retention, reduce prescribing risk, and unlock $30–$36 in new revenue per patient — without adding operational complexity.
Start Bundling
Most compounded GLP-1 programs compete on price and speed. The winners compete on outcomes, credibility, and margin.
Stand out in a crowded market by offering a medically supervised experience.
Create a true clinical loop with baseline and follow-up data.
Add predictable revenue on top of your existing medication economics.
Labs go from a cost center to a profit center.
This is incremental revenue — independent of medication margin.
| Active patients | Annualized provider revenue (3 reviews/year) |
|---|---|
| 500 | $45,000–$54,000 |
| 1,000 | $90,000–$108,000 |
| 10,000 | $900,000–$1,080,000 |
Programs with visible outcomes retain longer.
This is both growth and risk management.
We write results directly to the clinic's EMR.
Into Month 1 onboarding and optional follow-ups.
For real clinical services (collection + review).
Labs and logistics run quietly in the background.
Resale-friendly model designed for margin.
Works with your existing GLP-1 workflows.
Adds revenue without adding operational drag.
Strengthens your “medically supervised” brand.
We bridge the gap between the pharmacy logistics, diagnostic lab and the provider's EMR. You ship the meds; we handle the rest.
At scale, metabolic labs add $30–$36 per GLP-1 patient — while increasing retention and reducing prescribing risk.
Let's bundle labs into your GLP-1 program!